Casana Receives FDA Clearance for Heart Health Smart Toilet Seat

3 years ago

Casana obtained FDA clearance for measuring Heart Rate (HR) and Oxygen Saturation (SpO2)Sensors embedded in the toilet seat enable effortless…

Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates

3 years ago

Over 1,244 Alzheimer’s patients now enrolled in Phase 3 studies of simufilam.Completion of patient enrollment for Phase 3 program still…

Day One Reports First Quarter 2023 Financial Results and Corporate Progress

3 years ago

FIREFLY-1 clinical abstract selected for oral presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Leadership team…

Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging

3 years ago

Nanox.ARC Image of the Nanox ARC Nanox.ARC Image of the Nanox ARCNanox.ARC presents high powered digital X-ray tubes for 3D…

Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer

3 years ago

Strategic role strengthens NeuroStar® Advanced Therapy commercialization teamMALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a…

New GIMOTI Patent Listed in FDA Orange Book

3 years ago

Broad Formulation Patent Expands Protection for GimotiSOLANA BEACH, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty…

Acer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule

3 years ago

Availability: OLPRUVA™ drug in channel now anticipated in mid-June 2023 Awareness: 70% of metabolic treatment providers surveyed by Acer at…

Paratek Pharmaceuticals to Report Financial Results for First Quarter 2023 on May 9

3 years ago

BOSTON, May 01, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a…

Salarius Pharmaceuticals Reports No Adverse Safety Signals from Two Good Laboratory Practice Toxicology Studies with its Targeted Protein Degrader SP-3164

3 years ago

Submission of Investigational New Drug application expected in the second quarter of 2023 with start of Phase 1 trial expected…